| 0 (0%) | 10-10 16:32 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 29.86 | 1-year : | 30.34 |
| Resists | First : | 25.57 | Second : | 25.97 |
| Pivot price | 25.08  |
|||
| Supports | First : | 24.9 | Second : | 20.72 |
| MAs | MA(5) : | 25.15  |
MA(20) : | 25.12 |
| MA(100) : | 25.04 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 31.9 |
D(3) : | 26.9 |
| RSI | RSI(14): 54.8 |
|||
| 52-week | High : | 25.97 | Low : | 23.67 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SPMA ] has closed below upper band by 12.0%. Bollinger Bands are 18.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 25.19 - 25.32 | 25.32 - 25.44 |
| Low: | 24.84 - 24.97 | 24.97 - 25.11 |
| Close: | 24.94 - 25.15 | 25.15 - 25.36 |
Fri, 10 Oct 2025
Why SPMA stock could rally strongly - Portfolio Return Summary & Verified Swing Trading Watchlists - newser.com
Mon, 18 Aug 2025
Sound Point Meridian Capital Term Prefered Stock (NYSE:SPMA) - Seeking Alpha
Tue, 01 Jul 2025
Daily Derm Times: June 30, 2025 - Dermatology Times
Mon, 30 Jun 2025
FDA Reviews sPMA to Expand SKINVIVE by Juvéderm for Neck Line Treatment - Dermatology Times
Mon, 10 Feb 2025
SPMA 4P98 – 2025 National Bank Tennis Open (July 26 to August 7) – Sport Management - Brock University
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 4 (K) |
| Shares Short P.Month | 5 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.78 |
| Profit Margin | 25 % |
| Operating Margin | 71.1 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -195 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 1.34 |
| Price to Sales | 0 |
| Price to Cash Flow | -0 |
| Dividend | 0.17 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|